QuantumPharm, a Chinese artificial intelligence (AI) drug researcher backed by Tencent Holdings and HongShan, is eyeing an initial public offering (IPO) in Hong Kong to raise up to HK$1.13 billion ($144.7 million) to fuel its global expansion.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
